The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critique of the Evidence

Overview of attention for article published in PharmacoEconomics, June 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,500 followers.

Clinical & cost effectiveness of apremilast for treating active psoriatic arthritis: critique of the evidence https://t.co/wD23kZ8Gue

#HealthEconJA The Clinical and Cost Effectiveness of Apremilast for Treating Active Psoriatic Arthritis: A Critiqu… https://t.co/QPxX7mr6iK